Monthly Archives: June 2019

Safety and Tolerability, PK, and PD of an Antiplatelet GPVI Fab

  

Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab Voors-Pette C, Lebozec K, Dogterom P, Jullien L, Billiald P, Ferlan P, Renaud L, Favre-Bulle O, Avenard G, Machacek M, Pletan Y, Jandrot-Perrus M 2019 • Arterioscler Thromb Vasc Biol • [pdf]  • [Editorial] Objective– ACT017 is a novel, first in class, therapeutic antibody to platelet GPVI… Read more »

Thierry Lhermitte and FRM representatives at the LVTS

  
In the context of the FRM grant obtained by Fredéric Chaubet following the tender “Pionnier de la Recherche, Chimie pour la Médecine", Thierry Lhermitte, supporter of the FRM, and several foundation's members visited the laboratory. The project focuses on the treatment of intracranial aneuryms with novel bioactive devices and involves, in addition to the LVTS, two research teams from the... Read more »

Tridek‐One raises € 3 million from Advent France Biotechnology and Advent Life Science

  
Tridek One, Paris, June 4, 2019 ‐ Tridek One, a biotech company specialized in the development of products for the treatment of immune disorders, is pleased to announce a first round of funding of 3 million euros with leading investors Advent France Biotechnology and Advent Life Sciences. Tridek One was founded in 2018 by Dr. Giuseppina Caligiuri and Professor Antonino Nicoletti, researchers in... Read more »